# The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics.

> PubMed lists PMID 19758357 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-09-16 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-19758357-exenatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19758357-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19758357-exenatide-v1.json
- Content SHA-256: `f47552f0f638e871d34a0230363e4d329da4d863a935d007269965bc1d79da46`

## Claims and source pins

### Headline

The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. ([`pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922`](#source-pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922))

### Summary

PubMed lists PMID 19758357 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-09-16 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922`](#source-pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922))

### Paragraph 1

PubMed lists PMID 19758357 in Diabetes, obesity & metabolism as Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-09-16 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922`](#source-pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922`](#source-pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922))

## Sources

<a id="source-pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922"></a>
- **The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics. · retained source version 1:2026-01-28:current:7c349d2f6922dcea2ae458915b5105a1f34566a9abc6397bad41a1e51f3f9085** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19758357/) (`pubmed-observation-pmid-19758357-2026-01-28-7c349d2f6922`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19758357-exenatide-v1.json SHA-256: f47552f0f638e871d34a0230363e4d329da4d863a935d007269965bc1d79da46.